SIGN UP
LOG IN
News
IRTC
112.09
-0.03%
-0.03
IRTC Quantitative Stock Analysis
NASDAQ · 3d ago
While iRhythm Technologies (NASDAQ:IRTC) shareholders have made 59% in 5 years, increasing losses might now be front of mind as stock sheds 3.1% this week
IRhythm Technologies, Inc. (NASDAQ:IRTC) has a share price rise of 59% over five years, below the market return. The share price is down 18% in the last year. The company can boast revenue growth at a rate of 22% per year. It could be an opportunity for investors looking for underappreciated growth stocks.
Simply Wall St · 3d ago
Weekly Report: what happened at IRTC last week (0408-0412)?
Weekly Report · 4d ago
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 5d ago
IRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
Rosen Law Firm reminds purchasers of common stock of iRhythm Technologies, Inc. Between January 11, 2022 and May 30, 2023 of the important April 8, 2024 lead plaintiff deadline. A class action lawsuit has already been filed against the company. If you wish to serve as a lead plaintiff, you must move the Court no later than April 7, 2024. The Rosen Law Firm represents investors throughout the globe.
Barchart · 04/08 09:22
Weekly Report: what happened at IRTC last week (0401-0405)?
Weekly Report · 04/08 09:20
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
NASDAQ · 04/08 08:09
IRHYTHM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC
Investors have until April 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against iRhythm Technologies, Inc. The class action is pending in the U.S. District Court for the Northern District of California. Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti Jr.
Barchart · 04/05 18:00
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)
IRhythm Technologies, Inc. Reminds investors of the upcoming April 8, 2024 deadline to file a lead plaintiff motion in the class action lawsuit. The lawsuit is on behalf of investors who acquired iRhythm common stock between January 11, 2022 and May 30, 2023. The Law Offices of Frank R. Cruz reminds iRh Rhythm shareholders of the deadline to join the lawsuit.
Barchart · 04/05 12:06
Weekly Report: what happened at IRTC last week (0325-0329)?
Weekly Report · 04/01 09:19
iRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IRTC
Barchart · 04/01 04:45
Class Action Suit against iRhythm Technologies, Inc. (IRTC)
TipRanks · 03/27 05:30
The Gross Law Firm Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTC
IRhythm Technologies, Inc. (NASDAQ: IRTC) shareholders encouraged to contact the firm regarding possible lead plaintiff appointment. Shareholders who purchased shares of IRTC during the class period listed are encouraged to call the firm. The Gross Law Firm is representing shareholders in the case.
Barchart · 03/26 04:45
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't
IRhythm Technologies, Inc. Has a price-to-sales ratio of 6.8x. The company's forecast revenue growth is lower than the wider medical equipment industry. The high P/S puts investors in danger of paying an excessive premium for the company.
Simply Wall St · 03/25 12:24
Weekly Report: what happened at IRTC last week (0318-0322)?
Weekly Report · 03/25 09:20
Weekly Report: what happened at IRTC last week (0311-0315)?
Weekly Report · 03/18 09:20
Commit To Buy iRhythm Technologies At $70, Earn 6.9% Annualized Using Options
NASDAQ · 03/14 15:45
Weekly Report: what happened at IRTC last week (0304-0308)?
Weekly Report · 03/11 09:19
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
MacroGenics (MGNX), Irhythm Technologies (IRTC) and Vertex Pharmaceuticals (VRTX) have bullish sentiments. 3 analysts just weighed in on the Healthcare sector with bullish sentiments for the 3 stocks. MacroGenics is a Strong Buy with an average price target of $22.13.
TipRanks · 03/10 21:31
Press Release: iRhythm Announces Closing of -2-
This press release contains forward-looking statements that involve risks and uncertainties. IRhythm's expected use of the net proceeds from the offering and the effect of the capped call transactions are among the risks. The company's business and financial results may be affected by these and other factors.
Dow Jones · 03/08 21:30
More
Webull provides a variety of real-time IRTC stock news. You can receive the latest news about Irhythm Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About IRTC
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.